Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Journal of Chemical Information and Modeling|March 1, 2018
Shedding Light on Important Waters for Drug Design: Simulations versus Grid-Based MethodsDenis Bucher, Pieter Stouten, Nicolas TriballeauJournal of Medicinal Chemistry|April 2, 2005
Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4Nicolas Triballeau, Francine Acher, Isabelle Brabet, et al.Bioorganic & Medicinal Chemistry Letters|August 10, 2010
Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approachLaetitia Mony, Nicolas Triballeau, Pierre Paoletti, et al.Proceedings of the National Academy of Sciences of the United States of America|August 2, 2002
Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonistsAnne-Sophie Bessis, Philippe Rondard, Florence Gaven, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonistStephan Schann, Christel Menet, Paul Arvault, et al.Bioorganic & Medicinal Chemistry|August 17, 2010
Rose Bengal analogs and vesicular glutamate transporters (VGLUTs)Nicolas Pietrancosta, Albane Kessler, Franck-Cyril Favre-Besse, et al.Molecular Pharmacology|December 15, 2006
Amino-pyrrolidine tricarboxylic acids give new insight into group III metabotropic glutamate receptor activation mechanismMélanie Frauli, Nadia Hubert, Stephan Schann, et al.Neuron|December 17, 2008
High-potency olfactory receptor agonists discovered by virtual high-throughput screening: molecular probes for receptor structure and olfactory functionNicolas Triballeau, Eric Van Name, Guillaume Laslier, et al.Bioorganic & Medicinal Chemistry|April 15, 2025
Design, Synthesis, and Biological Implications of Autotaxin inhibitors with a Three-Point lock binding modeNicolas Desroy, Razvan Borza, Jörg Heiermann, et al.Journal of Medicinal Chemistry|March 12, 2010
A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonistsChelliah Selvam, Nadia Oueslati, Isabelle A Lemasson, et al.Pageof 2